BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 33057854)

  • 1. Tissue-Specific Fructose Metabolism in Obesity and Diabetes.
    Helsley RN; Moreau F; Gupta MK; Radulescu A; DeBosch B; Softic S
    Curr Diab Rep; 2020 Oct; 20(11):64. PubMed ID: 33057854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose and hepatic insulin resistance.
    Softic S; Stanhope KL; Boucher J; Divanovic S; Lanaspa MA; Johnson RJ; Kahn CR
    Crit Rev Clin Lab Sci; 2020 Aug; 57(5):308-322. PubMed ID: 31935149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. French Recommendations for Sugar Intake in Adults: A Novel Approach Chosen by ANSES.
    Tappy L; Morio B; Azzout-Marniche D; Champ M; Gerber M; Houdart S; Mas E; Rizkalla S; Slama G; Mariotti F; Margaritis I
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30060614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).
    Alwahsh SM; Gebhardt R
    Arch Toxicol; 2017 Apr; 91(4):1545-1563. PubMed ID: 27995280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between excessive dietary fructose consumption and paediatric fatty liver disease.
    DiStefano JK; Shaibi GQ
    Pediatr Obes; 2021 Jun; 16(6):e12759. PubMed ID: 33305889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people.
    Bray GA
    Adv Nutr; 2013 Mar; 4(2):220-5. PubMed ID: 23493538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction.
    Gutierrez JA; Liu W; Perez S; Xing G; Sonnenberg G; Kou K; Blatnik M; Allen R; Weng Y; Vera NB; Chidsey K; Bergman A; Somayaji V; Crowley C; Clasquin MF; Nigam A; Fulham MA; Erion DM; Ross TT; Esler WP; Magee TV; Pfefferkorn JA; Bence KK; Birnbaum MJ; Tesz GJ
    Mol Metab; 2021 Jun; 48():101196. PubMed ID: 33667726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary Fructose and Fructose-Induced Pathologies.
    Jung S; Bae H; Song WS; Jang C
    Annu Rev Nutr; 2022 Aug; 42():45-66. PubMed ID: 35995049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity.
    DiNicolantonio JJ; Mehta V; Onkaramurthy N; O'Keefe JH
    Prog Cardiovasc Dis; 2018; 61(1):3-9. PubMed ID: 29225114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease.
    Alberti G; Gana JC; Santos JL
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33212947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD.
    Song M; Vos MB; McClain CJ
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30469339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD.
    Laitakari A; Tapio J; Mäkelä KA; Herzig KH; Dengler F; Gylling H; Walkinshaw G; Myllyharju J; Dimova EY; Serpi R; Koivunen P
    J Mol Med (Berl); 2020 May; 98(5):719-731. PubMed ID: 32296880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
    Gugliucci A
    Med Hypotheses; 2016 Aug; 93():87-92. PubMed ID: 27372863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Way back for fructose and liver metabolism: bench side to molecular insights.
    Rebollo A; Roglans N; Alegret M; Laguna JC
    World J Gastroenterol; 2012 Dec; 18(45):6552-9. PubMed ID: 23236229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases.
    Gugliucci A
    Adv Nutr; 2017 Jan; 8(1):54-62. PubMed ID: 28096127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease.
    Hamza RT; Ahmed AY; Rezk DG; Hamed AI
    J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1345-1352. PubMed ID: 27442361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.